CRIS
Permanent URI for this communityhttps://investigadores.udd.cl/handle/123456789/1
Browse
8 results
Search Results
Now showing 1 - 8 of 8
- Some of the metrics are blocked by yourconsent settings
Item type:Publication, Scopus© Citations 2 1 - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Access to early diagnosis for attention-deficit/hyperactivity disorder among children and adolescents in Mexico City at specialized mental health services(2024) ;María Magdalena Martínez-Jaime ;Hortensia Reyes-Morales ;Ixchel Peyrot-NegreteMauricio Sebastián Barrientos-Álvarez<jats:title>Abstract</jats:title><jats:sec> <jats:title>Background</jats:title> <jats:p>In Mexico, this pioneering research was undertaken to assess the accessibility of timely diagnosis of Dyads [Children and adolescents with Attention Deficit Hyperactivity Disorder (ADHD) and their primary caregivers] at specialized mental health services. The study was conducted in two phases. The first phase involved designing an “Access Pathway” aimed to identify barriers and facilitators for ADHD diagnosis; several barriers, with only the teacher being identified as a facilitator. In the second phase, the study aimed to determine the time taken for dyads, to obtain a timely diagnosis at each stage of the Access Pathway. As well as identify any disparities based on gender and socioeconomic factors that might affect the age at which children can access a timely diagnosis.</jats:p> </jats:sec><jats:sec> <jats:title>Method</jats:title> <jats:p>In a retrospective cohort study, 177 dyads participated. To collect data, the Acceda Survey was used, based on the robust Conceptual Model Levesque, 2013. The survey consisted of 48 questions that were both dichotomous and polytomous allowing the creation of an Access Pathway that included five stages: the age of perception, the age of search, the age of first contact with a mental health professional, the age of arrival at the host hospital, and the age of diagnosis. The data was meticulously analyzed using a comprehensive descriptive approach and a nonparametric multivariate approach by sex, followed by post-hoc Mann-Whitney’s U tests. Demographic factors were evaluated using univariable and multivariable Cox regression analyses.</jats:p> </jats:sec><jats:sec> <jats:title>Results</jats:title> <jats:p>71% of dyads experienced a late, significantly late, or highly late diagnosis of ADHD. Girls were detected one year later than boys. Both boys and girls took a year to seek specialized mental health care and an additional year to receive a formal specialized diagnosis. Children with more siblings had longer delays in diagnosis, while caregivers with formal employment were found to help obtain timely diagnoses.</jats:p> </jats:sec><jats:sec> <jats:title>Conclusions</jats:title> <jats:p>Our findings suggest starting the Access Pathway where signs and symptoms of ADHD are detected, particularly at school, to prevent children from suffering consequences. Mental health school-based service models have been successfully tested in other latitudes, making them a viable option to shorten the time to obtain a timely diagnosis.</jats:p> </jats:sec>Scopus© Citations 1 2 - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Dimensión ética en la organización de la atención de salud(2013) ;Jaime Burrows ;Carlos Echeverría B ;Alejandro Goic G ;Carolina Herrera CCarlos Quintana V26Scopus© Citations 3 - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Barriers and Facilitators in Access to Diabetes, Hypertension, and Dyslipidemia Medicines: A Scoping Review(2022); ; ; ;Anita JasmenOscar Urrejola<jats:p><jats:bold>Objective:</jats:bold> Identify barriers and facilitators in access to medicines for diabetes, hypertension, and dyslipidemia, considering patient, health provider, and health system perspectives.</jats:p><jats:p><jats:bold>Methods:</jats:bold> Scoping review based on Joanna Briggs methodology. The search considered PubMed, Cochrane Library, CINAHL, Academic Search Ultimate, Web of Science, SciELO Citation Index, and grey literature. Two researchers conducted screening and eligibility phases. Data were thematically analyzed.</jats:p><jats:p><jats:bold>Results:</jats:bold> The review included 219 documents. Diabetes was the most studied condition; most of the evidence comes from patients and the United States. Affordability and availability of medicines were the most reported dimension and specific barrier respectively, both cross-cutting concerns. Among high- and middle-income countries, identified barriers were cost of medicines, accompaniment by professionals, long distances to facilities, and cultural aspects; cost of transportation emerges in low-income settings. Facilitators reported were financial accessibility, trained health workers, medicines closer to communities, and patients’ education.</jats:p><jats:p><jats:bold>Conclusion:</jats:bold> Barriers and facilitators are determined by socioeconomic and cultural conditions, highlighting the role of health systems in regulatory and policy context (assuring financial coverage and free medicines); providers’ role bringing medicines closer; and patients’ health education and disease management.</jats:p>Scopus© Citations 12 1 - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Use of health services among international migrant children – a systematic review(2018); ; ;Venla Lehti ;Eleonora UphoffSofia Astorga1Scopus© Citations 90 - Some of the metrics are blocked by yourconsent settings
Item type:Publication, The association between green space and depressive symptoms in pregnant women: moderating roles of socioeconomic status and physical activity(2016) ;R R C McEachan ;S L Prady ;G Smith ;L Fairley9Scopus© Citations 256 - Some of the metrics are blocked by yourconsent settings
Item type:Publication, 20Scopus© Citations 17 - Some of the metrics are blocked by yourconsent settings
Item type:Publication, Access to innovative medicines for metastatic melanoma worldwide: Melanoma World Society and European Association of Dermato-oncology survey in 34 countries(2018) ;L. Kandolf Sekulovic ;J. Guo ;S. Agarwala ;A. HauschildG. McArthur1Scopus© Citations 46